324 related articles for article (PubMed ID: 29361840)
1. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients.
Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S
Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840
[TBL] [Abstract][Full Text] [Related]
2. Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin.
Parker M; Bellec J; McFarland T; Scripps V; Appukuttan B; Hartzell M; Yeager A; Hady T; Mitrophanous KA; Stout T; Ellis S
Hum Gene Ther; 2014 May; 25(5):408-18. PubMed ID: 24460027
[TBL] [Abstract][Full Text] [Related]
3. Corneal transduction to inhibit angiogenesis and graft failure.
Murthy RC; McFarland TJ; Yoken J; Chen S; Barone C; Burke D; Zhang Y; Appukuttan B; Stout JT
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1837-42. PubMed ID: 12714613
[TBL] [Abstract][Full Text] [Related]
4. [Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].
Cursiefen C; Wenkel H; Martus P; Langenbucher A; Seitz B; Küchle M
Klin Monbl Augenheilkd; 2001 Jul; 218(7):484-91. PubMed ID: 11512248
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model.
Hosseini A; Lattanzio FA; Samudre SS; DiSandro G; Sheppard JD; Williams PB
J Ocul Pharmacol Ther; 2012 Apr; 28(2):194-201. PubMed ID: 22149555
[TBL] [Abstract][Full Text] [Related]
6. Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
Rehany U; Waisman M
Cornea; 1994 Sep; 13(5):447-53. PubMed ID: 7995070
[TBL] [Abstract][Full Text] [Related]
7. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
9. Corneal graft rejection.
Panda A; Vanathi M; Kumar A; Dash Y; Priya S
Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
[TBL] [Abstract][Full Text] [Related]
10. Clinical transplantation of individualized recipient serum-adapted cornea reduces the risk of graft rejection after keratoplasty.
Thanos S; Gatzioufas Z; Schallenberg M; König S; Meyer-Rüsenberg HW; Busse H
Cell Transplant; 2013; 22(3):477-91. PubMed ID: 23043892
[TBL] [Abstract][Full Text] [Related]
11. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
12. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
[TBL] [Abstract][Full Text] [Related]
13. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy approaches to prevent corneal graft rejection: where do we stand?
Ritter T; Wilk M; Nosov M
Ophthalmic Res; 2013; 50(3):135-40. PubMed ID: 23941996
[TBL] [Abstract][Full Text] [Related]
15. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
Xin M; Wang T; Shi W; Wu X
J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
[TBL] [Abstract][Full Text] [Related]
16. Human Bone Derived Collagen for the Development of an Artificial Corneal Endothelial Graft. In Vivo Results in a Rabbit Model.
Vázquez N; Chacón M; Rodríguez-Barrientos CA; Merayo-Lloves J; Naveiras M; Baamonde B; Alfonso JF; Zambrano-Andazol I; Riestra AC; Meana Á
PLoS One; 2016; 11(12):e0167578. PubMed ID: 27907157
[TBL] [Abstract][Full Text] [Related]
17. Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival.
Zhang W; Schönberg A; Hamdorf M; Georgiev T; Cursiefen C; Bock F
Br J Ophthalmol; 2022 Nov; 106(11):1617-1626. PubMed ID: 34810177
[TBL] [Abstract][Full Text] [Related]
18. Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection.
Tan Y; Cruz-Guilloty F; Medina-Mendez CA; Cutrufello NJ; Martinez RE; Urbieta M; Wilson D; Li Y; Perez VL
J Immunol; 2012 Jun; 188(12):5962-9. PubMed ID: 22593618
[TBL] [Abstract][Full Text] [Related]
19. [Rejection of corneal allografts].
Guilbert E; Laroche L; Borderie V
J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in a recipient cornea acts as a prognostic factor for corneal graft reaction development.
Sekelj S; Dekaris I; Balog T; Mahovne I; Krstonijevic EK; Janjetovic Z; Arar ZV; Aric I
Curr Eye Res; 2015 Apr; 40(4):407-14. PubMed ID: 24912114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
